Tiziana Life Sciences Reports Positive Phase 2a Clinical Data Exhibiting Positive Clinical Activity with Milciclib Monotherapy in Advanced Sorafenib-refractory or -intolerant Patients with Unresectable or Metastatic Hepatocellular Carcinoma
Tiziana Reports Phase 2a Clinical Data with Milciclib Monotherapy in Sorafenib-refractory or -intolerant patients with unresectable or metastatic Hepatocellular Carcinoma.
Integumen PLC (LON:SKIN) CEO Gerry Brandon speaks to Proactive London’s Andrew Scott soon after announcing the roll-out of a new Labskin test designed to clone the skin of volunteers in clinical
New Media Business Created, Board Appointments and Proposed Name Change to Iconic Labs Plc
The Group’s CEO, João Andrade, said, “I’d like to thank Alan Greenberg for his dedication to WideCells and I wish him all the best for the future.
Photo: FM Blockchain technology is poised to revolutionize the way individuals live their daily lives The Internet has been an undeniably disruptive force causing massive shifts that have cut
and then